Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
Johns Hopkins All Children's Hospital, St. Petersburg, Florida Johns Hopkins Hospital, Baltimore, Maryland Albert Einstein College of Medicine, Children's Hospital at Montefiore, The Bronx, New York New York Medical Center/ Maria Fareri Children's Hospital, Valhalla, New York